Keywords: synthelabo, product, portfolio, class, status, comments, -------------------------------------------------------------------------

Synthelabo's Product Portfolio

Article | 25 May 1992

*t Product Class Status Comments ------------------------------------------------------------------------- Tildiem (diltiazem) Ca antag Marketed Patent now expired Tildiem LP 300mg Ca antag Marketed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Betaxolol Hydrochloride

Kerlone

Cardizem LA

Diltiazem

Go to drug listing